These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9019346)

  • 1. [Plasma proteins in patients with liver steatosis and the effect of treatment of essential phospholipids].
    Turecký L; Kupcová V; Szántová M; Laktis K; Uhlíková E
    Bratisl Lek Listy; 1996 Oct; 97(10):625-8. PubMed ID: 9019346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of polyene phosphatidylcholine (Essentiale forte) in the treatment of liver steatosis and ultrasound findings--preliminary study].
    Horejsová M; Urban J
    Cas Lek Cesk; 1994 Jun; 133(12):366-9. PubMed ID: 8069893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipid parameters in patients with alcoholic fatty liver after treatment with essential phospholipids.
    Turecky L; Kupcova V; Szantova M; Uhlikova E
    Bratisl Lek Listy; 2003; 104(7-8):227-31. PubMed ID: 15168868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up.
    Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Brzozowski T; Konturek SJ; Korolczuk A
    J Physiol Pharmacol; 2014 Feb; 65(1):75-82. PubMed ID: 24622832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis.
    Cichoz-Lach H; Celinski K; Konturek PC; Konturek SJ; Slomka M
    J Physiol Pharmacol; 2010 Oct; 61(5):577-80. PubMed ID: 21081801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Positive effects of essential phospholipids and improvement of life style in patients with toxic liver injury].
    Holomán J; Glasa J; Hlavatý I; Veningerová M; Prachar V; Lukácsová M
    Bratisl Lek Listy; 1998 Feb; 99(2):75-81. PubMed ID: 9588082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of clinical efficiency of essential phospholipids and silymarin combination in nonalcoholic and alcoholic steatohepatitis].
    Iakimchuk GN; Gendrikson LN
    Eksp Klin Gastroenterol; 2011; (7):64-9. PubMed ID: 22364002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of essentiale with cholagogue in fatty liver complicated by cholecystitis for lowering the lithogenic properties of bile].
    Vakhrushev IaM; Suchkova EV; Khokhlacheva NA
    Eksp Klin Gastroenterol; 2002; (3):39-41, 119. PubMed ID: 12353386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of essentiale and cholagogum in prevention of cholelithiasis in fat hepatosis with concomitant cholecystitis].
    Vakhrushev IaM; Suchkova EV
    Ter Arkh; 2005; 77(2):18-21. PubMed ID: 15807444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Essential phospholipids in combined therapy of chronic circulatory insufficiency].
    Golochevskaia VS; Baranskaia EK; Trofimenko IV; Balakhonova NP; Burmakin IA; Kop'ev VI; Zadorozhnaia OO
    Klin Med (Mosk); 1997; 75(5):30-3. PubMed ID: 9235405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
    Loguercio C; Andreone P; Brisc C; Brisc MC; Bugianesi E; Chiaramonte M; Cursaro C; Danila M; de Sio I; Floreani A; Freni MA; Grieco A; Groppo M; Lazzari R; Lobello S; Lorefice E; Margotti M; Miele L; Milani S; Okolicsanyi L; Palasciano G; Portincasa P; Saltarelli P; Smedile A; Somalvico F; Spadaro A; Sporea I; Sorrentino P; Vecchione R; Tuccillo C; Del Vecchio Blanco C; Federico A
    Free Radic Biol Med; 2012 May; 52(9):1658-65. PubMed ID: 22343419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Essential phospholipids in the treatment of chronic hepatitis B virus infection].
    Hanták I; Boca M; Mikulecký M; Stancek D
    Vnitr Lek; 1990 Dec; 36(12):1164-71. PubMed ID: 2284713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[New Paradigm Challenges of Steatosis Treatment in the Practice Therapist].].
    Mehtiyev SN; Mehtiyeva OA
    Eksp Klin Gastroenterol; 2016; (5):51-57. PubMed ID: 28614645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regenerative tendencies in the alcoholic fatty liver under diet. Change in the dietary fat content].
    Irsigler K; Kryspin-Exner K; Mildschuh W
    Acta Hepatosplenol; 1970; 17(2):103-10. PubMed ID: 5524290
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of hepatoprotectors containing phospholipids on rats with experimental acute pancreatitis].
    Saratikov AS; Vengerovskiĭ AI; Mozzhelin ME; Sukhodolo IV
    Eksp Klin Farmakol; 2004; 67(4):35-7. PubMed ID: 15500043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids.
    Marsman HA; de Graaf W; Heger M; van Golen RF; Ten Kate FJ; Bennink R; van Gulik TM
    Br J Surg; 2013 Apr; 100(5):674-83. PubMed ID: 23456631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polyunsaturated phosphatidylcholine in the treatment of hepatic steatosis].
    Caruso L; Trischitta C; Bertino G; Amore MG; Rapisarda F; Calcara G
    Clin Ter; 1983 Nov; 107(4):279-90. PubMed ID: 6230201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.